Publicaciones en colaboración con investigadores/as de University of Turin (1)

2016

  1. Nivolumab ± ipilimumab treatment (Tx) efficacy, safety, and biomarkers in patients (Pts) with metastatic colorectal cancer (mCRC) with and without high microsatellite instability (MSI-H): results from the CheckMate-142 study

    Annals of Oncology, Vol. 27, pp. vi158